← Back to patent-cliff list

Cenerimod

Tier C — Watch / trade

Cenerimod

Idorsia Pharmaceuticals Ltd
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type

Targets:S1PR1

Indications (approved):狼疮肾炎, Systemic lupus erythematosus, Renal impairment, Hepatic function decline

Regional status

US
Phase III
2022-12-13
EU
Phase III
2022-12-13
China
Phase III
2026-05-11
Japan
Phase III
2022-12-13

Synthetic routes & intermediates1 routes

Originator routes × 0Optimised (non-patent) × 0Process routes × 1

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

ProcessRoute 1Steps 9 · Total yield 3.3 kg
M1—M21694-31-1M3110-52-1M46004-60-0M51368348-22-4M61495273-79-4M71495273-80-7M81122089-67-1M91150644-85-1M101980852-81-0M111980852-82-1M124909-95-9M1314347-78-5API · Cenerimod
CodeCAS No.Intermediate
---
-1694-31-1Availabletert-butyl 3-oxobutanoate
-110-52-1Available1,4-dibromobutane
-6004-60-01-cyclopentylethanone
-1368348-22-46-cyclopentyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid
-1495273-79-4methyl 6-cyclopentyl-2-oxo-1,2-dihydropyridine-4-carboxylate
-1495273-80-7methyl 2-chloro-6-cyclopentylisonicotinate
-1122089-67-12-cyclopentyl-6-methoxyisonicotinic acid
-1150644-85-1(R)-4-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)-3-ethyl-N-hydroxy-5-methylbenzimidamide
-1980852-81-0(R)-N-((2-cyclopentyl-6-methoxyisonicotinoyl)oxy)-4-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)-3-ethyl-5-methylbenzimidamide
-1980852-82-1(R)-5-(2-cyclopentyl-6-methoxypyridin-4-yl)-3-(4-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)-3-ethyl-5-methylphenyl)-1,2,4-oxadiazole
-4909-95-93-ethyl-4-hydroxy-5-methylbenzonitrile
-14347-78-5(R)-(2,2-dimethyl-1,3-dioxolan-4-yl)methanol

Frequently asked questions

What are the approved indications of Cenerimod?

Approved indications include: 狼疮肾炎, Systemic lupus erythematosus, Renal impairment, Hepatic function decline.

When does the Cenerimod patent expire?

No public expiry year is available for Cenerimod yet; this page updates once verified.

How many synthesis routes are recorded for Cenerimod?

1 synthesis routes are recorded; the shortest is 9 steps with 3.3 kg total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Cenerimod intermediates?

2 intermediate CAS of Cenerimod are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Cenerimod intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-21